Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about METABOLIC DYSFUNCTION: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | METABOLIC DYSFUNCTION |
Knowledge base pages for this entity
graph TD
METABOLIC_DYSFUNCTION[METABOLIC DYSFUNCTION]
METABOLIC_DYSFUNCTION -->|contributes to| Alzheimer_s_Disease_Progressio[Alzheimer's Disease Progression]
METABOLIC_DYSFUNCTION -->|risk_factor_for| Alzheimer_S_Disease[Alzheimer'S Disease]
METABOLIC_DYSFUNCTION -->|causes| Alzheimer_s_disease[Alzheimer's disease]
Extracellular_Vesicles[Extracellular Vesicles] -->|mediates| METABOLIC_DYSFUNCTION
NAD__Biosynthesis[NAD+ Biosynthesis] -->|contributes to| METABOLIC_DYSFUNCTION
__lipoic_acid[α-lipoic acid] -.protects against.-> METABOLIC_DYSFUNCTION
Gut_Microbiota[Gut Microbiota] -->|modulates| METABOLIC_DYSFUNCTION
plasma_proteins[plasma proteins] -->|involved_in| METABOLIC_DYSFUNCTION
AQP1[AQP1] -->|modulates| METABOLIC_DYSFUNCTION
MTOR[MTOR] -->|activates| METABOLIC_DYSFUNCTION
mTOR[mTOR] -->|activates| METABOLIC_DYSFUNCTION| Target | Relation | Type | Str |
|---|---|---|---|
| Alzheimer's Disease Progression | contributes_to | phenotype | 0.90 |
| Alzheimer'S Disease | risk_factor_for | disease | 0.80 |
| age-related diseases | associated_with | disease | 0.80 |
| Alzheimer's disease | causes | disease | 0.70 |
| Source | Relation | Type | Str |
|---|---|---|---|
| Tumour Extracellular Vesicles | associated_with | process | 0.92 |
| Metabolic Dysfunction-Associated Steatotic Liver Disease | associated_with | disease | 0.90 |
| Extracellular Vesicles | mediates | process | 0.88 |
| Gut Microbiota | modulates | cell_type | 0.85 |
| NAD+ Biosynthesis | contributes_to | pathway | 0.85 |
| Aqp1 Blockade | associated_with | mechanism | 0.85 |
| α-lipoic acid | protects_against | compound | 0.85 |
| plasma proteins | involved_in | protein | 0.80 |
| AQP1 | modulates | gene | 0.75 |
| MTOR | activates | protein | 0.70 |
| mTOR | activates | protein | 0.70 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| TREM2 R47H Variant-Driven Metabolic Dysfunction as the Prima | 0.858 | neurodegeneration | How do different microglial subtypes (DA |
| Apolipoprotein E4-Mediated Metabolic Dysfunction Correction | 0.380 | metabolomics | Metabolomic signatures of neurodegenerat |
Scientific analyses that reference this entity
No analyses mention this entity
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| NAD depletion effects on monocyte/macrophage differentiation | exploratory | Inflammatory bowel disease | 0.900 | 0.00 | Primary mouse and human monocy | proposed | N/A |
| FK866 treatment in DSS-induced colitis mouse model | validation | Inflammatory bowel disease (co | 0.900 | 0.00 | DSS-induced colitis mice | proposed | N/A |
| FK866 in azoxymethane/DSS colitis-associated cancer model | validation | Colitis-associated cancer | 0.850 | 0.00 | AOM/DSS-treated mice | proposed | N/A |
| FK866 mechanism validation in Rag1-/- mice | validation | Inflammatory bowel disease | 0.850 | 0.00 | Rag1-/- mice with DSS-induced | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
No debates reference this entity
Hypotheses and analyses mentioning METABOLIC DYSFUNCTION in their description or question text
No additional research found